NLC
38
268K
34
3.80
11
0.11
- Stages of investment
- Areas of investment
Investments analytics
Analytics
- Total investments
- 38
- Lead investments
- 11
- Rounds per year
- 3.80
- Follow on index
- 0.11
- Investments by industry
- Health Care (33)
- Medical Device (26)
- Medical (23)
- Health Diagnostics (12)
- Software (5) Show 25 more
- Investments by region
-
- Netherlands (31)
- United States (1)
- The Netherlands (1)
- Austria (2)
- United Kingdom (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Group Appearance index
- 0.11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| FarmWise | 01 Jun 2022 | Software, Robotics, AgTech, Agriculture, Farming | Early Stage Venture | 45M | United States, California, San Francisco |
| envoPAP | 15 Nov 2019 | CleanTech, Sustainability, Advanced Materials, GreenTech, Packaging Services, Green Consumer Goods, Paper Manufacturing | Seed | 548K | United Kingdom, London, England |
| Respiosa | 01 Dec 2019 | Health Care, Medical Device, Medical, Personal Health, Home Health Care | Seed | North Holland, Amsterdam, Netherlands | |
| SERDA therapeutics | 03 Jun 2024 | Seed | 2M | United States, Missouri, Netherlands |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.